1. Home
  2. ZLAB vs ENVX Comparison

ZLAB vs ENVX Comparison

Compare ZLAB & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.67

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$8.97

Market Cap

2.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
ENVX
Founded
2013
2006
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ZLAB
ENVX
Price
$18.67
$8.97
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$57.22
$17.14
AVG Volume (30 Days)
810.7K
6.2M
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$441,629,000.00
$30,273,000.00
Revenue This Year
$30.20
$36.91
Revenue Next Year
$34.71
$117.80
P/E Ratio
N/A
N/A
Revenue Growth
24.14
45.98
52 Week Low
$18.61
$5.27
52 Week High
$44.34
$16.49

Technical Indicators

Market Signals
Indicator
ZLAB
ENVX
Relative Strength Index (RSI) 21.76 51.73
Support Level $19.40 $7.27
Resistance Level $20.22 $9.17
Average True Range (ATR) 0.53 0.54
MACD 0.20 0.28
Stochastic Oscillator 5.02 92.17

Price Performance

Historical Comparison
ZLAB
ENVX

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

Share on Social Networks: